Owing to this, we believe PD can promote the production of LPA, which can inhibit intestinal chloride secretion in preclinical in vitro studies and in NHE3 upregulation of DRA expression (Singla et al., 2012), and contribute significantly to PD treatment of DHD. The gene discussed is SLC26A3; the disease is Doyne honeycomb retinal dystrophy.